Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$336K Buy
2,968
+156
+6% +$15.5K 0.03% 313
2026
Q1
$265K Sell
2,812
-502
-15% -$50.1K 0.02% 428
2025
Q4
$327K Sell
3,314
-1,103
-25% -$107K 0.03% 348
2025
Q3
$375K Buy
+4,417
New +$349K 0.03% 307
2025
Q1
Sell
-3,282
Closed -$227K 504
2024
Q4
$227K Buy
3,282
+156
+5% +$11.1K 0.02% 512
2024
Q3
$207K Sell
3,126
-762
-20% -$48.6K 0.02% 497
2024
Q2
$236K Sell
3,888
-466
-11% -$26.4K 0.02% 443
2024
Q1
$248K Sell
4,354
-6,978
-62% -$419K 0.02% 452
2023
Q4
$712K Buy
+11,332
New +$641K 0.06% 196

Other funds holding INCY

Trust Point Inc's INCY Position: Q2 2026 in Review

Trust Point Inc increased its Incyte (INCY) stake by 5.5% in Q2 2026, buying an estimated $15.5K and bringing the position to 2,968 shares worth $336K. The position accounts for 0.03% of the portfolio, ranked #313.

Trust Point Inc first reported a position in INCY in Q4 2023 and has held it in 9 quarters since. The position peaked at $712K in Q4 2023. 141 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Trust Point Inc held 2,968 shares of Incyte worth $336K as of Q2 2026.
  • Trust Point Inc bought 156 Incyte shares in Q2 2026, an estimated $15.5K.
  • Incyte made up 0.03% of Trust Point Inc's portfolio in Q2 2026, its #313 holding.
  • Trust Point Inc first reported a position in Incyte in Q4 2023 and has held it in 9 quarters since.
  • Trust Point Inc's Incyte position peaked at $712K in Q4 2023.
  • 141 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Trust Point Inc's 13F filing for Q2 2026, filed 8 Jul 2026.